Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study.
Larry D DillonMichael McPheeRobert S DavidsonAnn P QuickBrian MartinKyle R CovingtonOlga ZolochevskaRobert W CookJohn T VettoAbel D JarellMartin D FlemingPublished in: Current medical research and opinion (2022)
The 31-GEP can stratify patient recurrence risk in patients with CM, and clinicians understand and apply the prognostic ability of the 31-GEP test to alter patient management in risk-appropriate directions.